We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitiv... MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland. Show more
International Business Machines (NYSE:IBM) – According to the South China Morning Post, IBM has closed its R&D operations in China, laying off over 1,000 employees due to geopolitical...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.195 | -14.2335766423 | 1.37 | 1.43 | 1.17 | 600829 | 1.26179947 | CS |
4 | -0.815 | -40.9547738693 | 1.99 | 2.7 | 1.17 | 2489552 | 1.92523933 | CS |
12 | 0.465 | 65.4929577465 | 0.71 | 5.01 | 0.51 | 6265481 | 3.41715462 | CS |
26 | -0.015 | -1.26050420168 | 1.19 | 5.01 | 0.51 | 2900290 | 3.36002127 | CS |
52 | -3.385 | -74.2324561404 | 4.56 | 6.4 | 0.51 | 1681093 | 3.1587548 | CS |
156 | -5.825 | -83.2142857143 | 7 | 7.9799 | 0.51 | 1509078 | 3.18438858 | CS |
260 | -5.825 | -83.2142857143 | 7 | 7.9799 | 0.51 | 1509078 | 3.18438858 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions